FDA Investigator Zhenzhen Liu, PhD
Zhenzhen Liu, PhD has conducted inspections on 3 sites in 2 countries as of 20 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
20 Dec 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Denmark
FDA Investigators that have inspected at least one site in common with Zhenzhen Liu, PhD:
Alexey Khrenov, PhD,
Amy Devlin, PhD,
Amy Hsu, PhD,
Ashutosh Rao, PhD,
Benjamin J Smith,
Bo Chi, PhD,
Bonita S Chester,
Brooke K Higgins,
Brooke K Seeman,
CDR Donald Ertel,
Charles Yuanchia Kuo, PhD,
Christopher Downey, PhD,
Colleen Thomas, PhD,
Devaughn Edwards,
Douglas A Campbell,
Dr. Zhihao Qiu (Peter), PhD,
Emest F Bizjak,
Geneve M Maxwell,
Geneve M Parks,
Howard Anderson, PhD,
Jacek Cieslak, PhD,
Jason F Chancey,
Jazmine N Still,
Jee Chung, PhD,
Jeffrey A Sommers,
Jeffrey D Meng,
Lakshmi Narasimhan, PhD,
Larry K Austin,
Leopold Kong, PhD,
Leslie Arivera Rosado, PhD,
Lisa L Flores,
Maria Gutierrez Lugo, PhD,
Mary Kaulee,
Meisha R Sampson,
Meisha Waters,
Melissa J Garcia,
Michael G Truchan,
Michael Shanks, MS,
Michele L Forster, PhD,
Muna Algharibeh,
Patricia F Hughes, PhD,
Paula A Trost,
Penny H Mccarver,
Rebecca E Dombrowski,
Reyes Candau Chacon, PhD,
Riley C Myers, PhD,
Robert M Barbosa,
Seneca D Toms,
Simon Williams, PhD,
Simone E Pitts,
Sonya M Edmonds,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Thuy T Nguyen, LCDR,
Veronica Fuentes, MS,
Xiaoxiao Pan, PhD,
Xuhong Li,
Yuan Chia Kuo,
Yun Wu, PhD
Zhenzhen Liu, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2018 | FDA 483 | Exelead, Inc. - Form 483, 2018-05-15 |
October, 2018 | FDA 483 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2018-10-26 |
May, 2021 | FDA 483 | AGC Biologics A/S - Form 483, 2021-05-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more